Utility of Ankle-Brachial Index (ABI) in Diagnosing Peripheral Artery Disease
The ABI should be used as the first-line noninvasive test for diagnosing PAD when clinical suspicion exists based on symptoms like leg pain on walking that resolves with rest, with an ABI <0.90 confirming the diagnosis. 1
Diagnostic Performance
The ABI demonstrates strong diagnostic utility for PAD detection:
- Pooled sensitivity: 65-75% and specificity: 86-89% when using the threshold of ≤0.90 2, 3
- Diagnostic odds ratio of 15-18, indicating robust discriminatory ability 2, 3
- Positive likelihood ratio of 4.18-6.11, meaning a positive test substantially increases the probability of PAD 2, 3
- Area under the curve of 0.86-0.87, demonstrating good overall diagnostic accuracy 2, 3
The test performs particularly well when stenosis involves the femoropopliteal vessels, achieving sensitivity up to 97% with automated oscillometric methods 4.
Proper Measurement Technique
To maximize diagnostic accuracy, follow this specific sequence 1:
- Measure in order: First arm → first posterior tibial (PT) artery → first dorsalis pedis (DP) artery → other PT artery → other DP artery → other arm
- Repeat the first arm measurement if it exceeds the second arm by >10 mm Hg (discard the initial reading)
- Use the lower of PT or DP pressures for each leg to calculate ABI, as this identifies more patients at risk and prevents missing unilateral disease 1
- Measure both legs - using only the higher ABI between legs will miss patients with significant unilateral disease who remain at high cardiovascular risk 1
Diagnostic Thresholds and Interpretation
ABI <0.90: Confirms PAD diagnosis (Class I, Level A evidence) 1
ABI 0.91-1.00: Borderline range requiring further evaluation 1
ABI >0.90 with persistent clinical suspicion: Proceed to post-exercise ABI or imaging. A post-exercise ankle pressure decrease >30 mm Hg or ABI decrease >20% indicates PAD 1
ABI >1.40: Suggests non-compressible vessels (arterial calcification). Use toe-brachial index or imaging instead 1
Critical Limitations and Pitfalls
Arterial calcification (common in diabetes and chronic kidney disease) produces falsely elevated ABI readings >1.40, rendering the test unreliable in these patients 5. When encountering this, immediately switch to toe-brachial index or vascular imaging 1.
Low sensitivity in asymptomatic patients means ABI is less useful for screening asymptomatic populations 6, 5. The test performs optimally in symptomatic patients with intermittent claudication.
Operator technique matters significantly. Automated oscillometric methods outperform manual doppler when used by inexperienced operators, showing higher specificity (89% vs 56%) 4. Ensure proper training in vascular anatomy, doppler technique, and reproducible measurements 1.
Enhanced Diagnostic Accuracy
Recent evidence suggests combining ABI with pulse volume wave parameters (inter-arm systolic blood pressure disparity ≥10 mmHg, inter-leg systolic blood pressure difference ≥15 mmHg, and mean arterial pressure proportion) improves diagnostic accuracy to an AUC of 0.924, with 88.6% sensitivity and 85.4% specificity 7. This integrated approach is particularly valuable in patients over 75 years and those with diffuse arterial disease 7.
Beyond Diagnosis: Cardiovascular Risk Stratification
ABI <0.90 or >1.40 independently predicts increased cardiovascular mortality and events, regardless of PAD symptoms or other risk factors 1. For cardiovascular mortality, the hazard ratio is 4.2 in men and 3.5 in women compared to normal ABI 1. However, adding ABI to Framingham Risk Score provides only modest reclassification improvement for predicting cardiovascular events 6.
Clinical Applications
Use ABI for:
- Confirming PAD diagnosis in patients with exertional leg pain
- Screening before compression therapy to ensure adequate arterial perfusion
- Assessing wound healing potential in lower extremity ulcers 5
- Identifying high cardiovascular risk patients who warrant aggressive risk factor modification
Do not use aspirin solely based on screen-detected low ABI in asymptomatic patients - a large trial (n=3,350) showed no cardiovascular benefit and potential increased bleeding risk 6.